Norethindrone

DRUG6 trials

Conditions

Blood Coagulation DisordersContraceptionHealthyMenstrual Flow AlteredOvulationPrimary-progressive Multiple SclerosisRelapsing-remitting Multiple SclerosisSecondary-progressive Multiple Sclerosis

Phase 1

A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone

CompletedNCT02652650

Janssen Research & Development, LLCHealthy

Start: 2015-12-31End: 2016-06-30Updated: 2016-06-06

Phase 2

Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition

NCT01466114

University of California, Los AngelesPrimary-progressive Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis, Secondary-progressive Multiple Sclerosis

Start: 2011-10-31End: 2022-04-30Target: 64Updated: 2019-11-06

Phase 3

Ovulation Incidence in Oral Contraceptive Users

CompletedNCT03106454

University of Southern CaliforniaContraception, Ovulation

Start: 2014-08-31End: 2024-01-01Updated: 2025-12-26

Phase 4

Norethindrone for the Delay of Menstruation

CompletedNCT03594604

Wayne State UniversityMenstrual Flow Altered

Start: 2007-06-15End: 2007-12-15Updated: 2018-07-20

Unknown Phase

Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus

CompletedNCT00006133

National Center for Research Resources (NCRR)Systemic Lupus Erythematosus

Start: 2000-06-30Target: 970Updated: 2005-06-24

The Effect of the Mini-pill on Blood Factors in Women at Increased Risk for Forming Blood Clots

TerminatedNCT00580424

University of VermontBlood Coagulation Disorders, Women's Health

Start: 2007-12-31End: 2009-07-31Target: 20Updated: 2010-06-28

Related Papers

Norethindrone is superior to combined oral contraceptive pills in short-term delay of menses and onset of breakthrough bleeding: a randomized trial.

2019-05-2810 citations